Impact BioMedical Inc.
IBOAMEXHealthcare● Active
$0.53
$-0.03(-5.93%)
Market Cap$6581250
P/E Ratio—
52W High$1.95
52W Low$0.362
Impact BioMedical Inc. (IBO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IBO · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.03M | $1.62M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.42M | $0.00M | $0.00M | $1.11M | $1.11M |
| Gross Profit | ($0.39M) | $1.62M | $0.00M | ($1.11M) | ($1.11M) |
| Gross Margin %(computed) | — | 100.00% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.34M | $0.06M | $1.69M | $1.23M | $1.08M |
| G&A Expenses | $1.95M | $0.71M | $1.04M | $1.05M | $1.05M |
| Total Operating Expenses | $3.88M | $1.24M | $4.03M | $2.34M | $2.07M |
| Operating Income | ($4.27M) | $0.38M | ($4.03M) | ($3.45M) | ($3.19M) |
| Operating Margin %(computed) | — | 23.67% | — | — | — |
| Interest Income | $0.01M | $0.00M | $0.01M | $0.02M | $0.17M |
| Interest Expense | $0.79M | $0.12M | $0.44M | $0.46M | $0.30M |
| Income Before Tax | ($14.45M) | ($1.43M) | ($4.41M) | ($7.88M) | ($3.24M) |
| Income Tax Expense | ($2.58M) | $0.03M | $0.00M | ($0.62M) | ($1.40M) |
| Net Income | ($11.84M) | ($1.43M) | ($4.34M) | ($7.05M) | ($1.30M) |
| Net Margin %(computed) | — | -88.01% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.38 | $-0.01 | $-0.07 | $-0.61 | $-0.61 |
| Wtd Avg Shares | 31.55M | 41.75M | 60.25M | 11.50M | 11.50M |
| EBITDA | ($12.51M) | ($1.07M) | ($2.84M) | ($2.34M) | ($2.07M) |
| EBITDA Margin %(computed) | — | -66.03% | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Impact BioMedical Inc. data
About Impact BioMedical Inc. (IBO) Income Statement
Impact BioMedical Inc. (IBO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, IBO reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -1225.00%), and net income of ($0.01B) — a net profit margin of -36993.75%.
Frequently asked questions
IBO · 4 questionsImpact BioMedical Inc. (IBO) reported revenue of $0.00B for 2025, down 98.0% year-over-year.
IBO revenueIBO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09